Melipharm Overview

  • Founded
  • 2011
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Investors
  • 1

Melipharm General Information


Developer of sterile medical devices intended for the treatment of acute and chronic wounds. The company's sterile medical devices is a natural product which comes from the selection of honey essences whose anti-bacterial and healing properties have been validated by the researchers in the laboratory, enabling doctors to treat acute and chronic wounds based on selected mono floral honey.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Devices and Supplies
Other Industries
Medical Supplies
Primary Office
  • 1 avenue d'Ester
  • Cedex
  • 87069 Limoges
  • France
+33 06 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Melipharm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 01-Oct-2014 Completed Generating Revenue
To view Melipharm’s complete valuation and funding history, request access »

Melipharm Patents

Melipharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170072024-A1 Antimicrobial composition comprising a carbohydrate, glucose oxidase and zinc oxide Abandoned 14-May-2014 0000000000
FR-3020948-B1 Antimicrobial composition Active 14-May-2014 0000000000
FR-3020948-A1 Antimicrobial composition Granted 14-May-2014 0000000000
EP-3142687-A1 Antimicrobial composition comprising a carbohydrate, glucose oxydase and zinc oxide Pending 14-May-2014 0000000000 0
FR-3007291-B1 Cicatrisante composition and use Expired - Fee Related 20-Jun-2013 A61K35/644

Melipharm Executive Team (1)

Name Title Board Seat Contact Info
M Fabien Quero President
To view Melipharm’s complete executive team members history, request access »

Melipharm Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Limousin Business Angels Angel Group Minority 000 0000 000000 0
To view Melipharm’s complete investors history, request access »